Search - tctmd.com

Displaying 361 - 380 of 446

Sort: Relevancy | Date

Presentation TVT 2017

Case Tutorial #1: A Case of Bicuspid Aortic Valve Disease With Heavy Leaflet Calcification Case Presentation

Presenter: Christopher U. Meduri

June 15, 2017

Presentation TVT 2017

CT-Based Classification of Bicuspid Aortic Valve Disease: Implications for TAVR Treatment

Presenter: Hasan Jilaihawi

June 15, 2017

Presentation TVT 2017

A Surgeons Perspective of Bicuspid Aortic Valve Disease Anatomic Patterns Favorable for TAVR

Presenter: Mark J. Russo

June 15, 2017

Manuscript

Bicuspid Aortic Valve Disease: New Insights

May 26, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Shelley Wood

March 24, 2017

Presentation SIF 2017

Bicuspid Valve Disease

Presenter: Michael J. Reardon

March 11, 2017

Presentation SIF 2017

Bicuspid Aortic Valve Disease and TAVR

Presenter: Michael J. Reardon

March 11, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Conference News AHA 2016

Local Anesthesia for TAVR Is Safe, Gets Patients Home More Quickly: Meta-analysis

Todd Neale

November 15, 2016

News Conference News AHA 2016

La Anestesia Local durante la Realización de TAVR es Segura y los Pacientes se van Antes a Casa: Meta-análisis

Todd Neale

November 15, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

Presentation TCT 2016

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben

November 01, 2016

Presentation TCT 2016

Severe Bicuspid Aortic Valve Disease

Presenter: Jean-Claude Laborde, Wilson Y. Szeto, Vinayak Bapat

October 31, 2016

Presentation TCT 2016

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples)

Presenter: A. Pieter Kappetein, Allan Schwartz, Mathew Williams

October 30, 2016

Presentation TCT 2016

Bicuspid Aortic Valve Disease: Epidemiology, Anatomy, Classification, and Special Considerations for TAVR

Presenter: A. Pieter Kappetein, Allan Schwartz, Lars Sondergaard

October 30, 2016

Presentation TCT 2016

TAVR 2016: Making the Case For New Patient Subsets (Low Risk, Bicuspid, etc.)

Presenter: Marian C. Hawkey, Patricia Keegan

October 30, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

Michael O'Riordan

July 05, 2016

Advertisement

Case Tutorial #1: A Case of Bicuspid Aortic Valve Disease With Heavy Leaflet Calcification Case Presentation

CT-Based Classification of Bicuspid Aortic Valve Disease: Implications for TAVR Treatment

A Surgeons Perspective of Bicuspid Aortic Valve Disease Anatomic Patterns Favorable for TAVR

Bicuspid Aortic Valve Disease: New Insights

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Bicuspid Valve Disease

Bicuspid Aortic Valve Disease and TAVR

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Local Anesthesia for TAVR Is Safe, Gets Patients Home More Quickly: Meta-analysis

La Anestesia Local durante la Realización de TAVR es Segura y los Pacientes se van Antes a Casa: Meta-análisis

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Severe Bicuspid Aortic Valve Disease

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples)

Bicuspid Aortic Valve Disease: Epidemiology, Anatomy, Classification, and Special Considerations for TAVR

TAVR 2016: Making the Case For New Patient Subsets (Low Risk, Bicuspid, etc.)

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content